17-Mar-2008 - The costs of introducing any formal good manufacturing practice (GMP) requirements for potentially high-risk pharmaceutical excipients in the European Union would far exceed the likely benefits, concludes an impact assessment for the European Commission.
Link to Article
in-pharmatechnologist.com
|
|
||||
|
Monday, March 17
GMP an unnecessary burden for excipients, review concludes
by
Alex Hsieh on behalf of Professor Henry Wang
on Mon 17 Mar 2008 11:44 PM EDT
Pharma: why the wandering eye towards emerging markets?
by
Alex Hsieh on behalf of Professor Henry Wang
on Mon 17 Mar 2008 11:43 PM EDT
17-Mar-2008 - Outsourcing-Pharma explores the driving force behind the pharma industry's escalating wandering eye towards emerging markets.
Link to Article in-pharmatechnologist.com |
Search
Links
|
|||